BUZZ-Cipher Pharmaceuticals Inc: Buys dermatology company
** Canadian drug developer's U.S.-listed shares up 15 pct at $11.15
** Company says it acquired privately held dermatology company Innocutis Holdings LLC for $45.5 mln in cash to enter U.S. commercial market
** Cipher says it expects acquisition to add to earnings within two years
** Company to also pay up to $3 mln in cash in incentives to Innocutis management over next 3 years on achievement of some financial targets
** Up to Friday's close, stock had fallen 27 pct this year
© Thomson Reuters 2017 All rights reserved.